Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses - PubMed
Randomized Controlled Trial
Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses
Karen L Teff et al. J Clin Endocrinol Metab. 2009 May.
Abstract
Context: Compared with glucose-sweetened beverages, consumption of fructose-sweetened beverages with meals elevates postprandial plasma triglycerides and lowers 24-h insulin and leptin profiles in normal-weight women. The effects of fructose, compared with glucose, ingestion on metabolic profiles in obese subjects has not been studied.
Objective: The objective of the study was to compare the effects of fructose- and glucose-sweetened beverages consumed with meals on hormones and metabolic substrates in obese subjects.
Design and setting: The study had a within-subject design conducted in the clinical and translational research center.
Participants: Participants included 17 obese men (n = 9) and women (n = 8), with a body mass index greater than 30 kg/m(2).
Interventions: Subjects were studied under two conditions involving ingestion of mixed nutrient meals with either glucose-sweetened beverages or fructose-sweetened beverages. The beverages provided 30% of total kilocalories. Blood samples were collected over 24 h.
Main outcome measures: Area under the curve (24 h AUC) for glucose, lactate, insulin, leptin, ghrelin, uric acid, triglycerides (TGs), and free fatty acids was measured.
Results: Compared with glucose-sweetened beverages, fructose consumption was associated with lower AUCs for insulin (1052.6 +/- 135.1 vs. 549.2 +/- 79.7 muU/ml per 23 h, P < 0.001) and leptin (151.9 +/- 22.7 vs. 107.0 +/- 15.0 ng/ml per 24 h, P < 0.03) and increased AUC for TG (242.3 +/- 96.8 vs. 704.3 +/- 124.4 mg/dl per 24 h, P < 0.0001). Insulin-resistant subjects exhibited larger 24-h TG profiles (P < 0.03).
Conclusions: In obese subjects, consumption of fructose-sweetened beverages with meals was associated with less insulin secretion, blunted diurnal leptin profiles, and increased postprandial TG concentrations compared with glucose consumption. Increases of TGs were augmented in obese subjects with insulin resistance, suggesting that fructose consumption may exacerbate an already adverse metabolic profile present in many obese subjects.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c41d/2684484/e4eac6fac609/zeg0050964540001.gif)
Effect of glucose-sweetened beverages (solid lines) and fructose-sweetened beverages (dashed lines) on plasma concentrations of fructose (A), glucose (B), lactate (C), and free fatty acid levels (D) in obese men and women consuming beverages with meals (mean ±
sem, n = 17). Fructose was undetectable on the day glucose-sweetened beverages were consumed. Plasma glucose levels were significantly lower (F = 9.0, P < 0.00001, time × treatment), and plasma lactate levels were elevated (F = 13.7 P < 0.00001, time × treatment) after fructose compared with glucose consumption. No significant differences were observed in plasma free fatty acid concentrations between treatments.
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c41d/2684484/90a871c65252/zeg0050964540002.gif)
Effect of glucose-sweetened beverages (solid lines) andfructose-sweetened beverages (dashed lines) on plasma concentrations of insulin (left panel) and the percent change of plasma leptin from baseline (right panel) in obese human subjects (mean ±
sem, n = 17). Plasma insulin (F = 2.15, P < 0.003, time × treatment) and leptin levels (F = 2.55, P < 0.00001, time × treatment) were significantly lower after fructose compared with glucose consumption. Baseline leptin values were 20.7 ± 10.69 (HGl) and 20.3 ± 11.0 (HFr).
![Figure 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c41d/2684484/9a34e9098ceb/zeg0050964540003.gif)
Effect of glucose-sweetened beverages (solid lines) and fructose-sweetened beverages (dashed lines) on plasma TG concentrations in obese subjects (mean ±
sem, n = 17). Plasma TG levels were significantly elevated after fructose compared with glucose consumption. (F = 4.99 P < 0.0001, treatment × time interaction).
![Figure 4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c41d/2684484/034fb20d5d2a/zeg0050964540004.gif)
TG responses to consumption of glucose-sweetened (left panel) and fructose-sweetened beverages (right panel) with meals in insulin-sensitive (n = 10, dashed line, round symbol) and insulin-resistant obese subjects (n = 7, solid line, square symbol). Plasma TG concentrations were significantly elevated after fructose consumption in both insulin-sensitive and insulin-resistant subjects (F = 5.1, P < 0.0001, treatment × time).
Similar articles
-
Stanhope KL, Griffen SC, Bair BR, Swarbrick MM, Keim NL, Havel PJ. Stanhope KL, et al. Am J Clin Nutr. 2008 May;87(5):1194-203. doi: 10.1093/ajcn/87.5.1194. Am J Clin Nutr. 2008. PMID: 18469239 Free PMC article. Clinical Trial.
-
Campos V, Despland C, Brandejsky V, Kreis R, Schneiter P, Boesch C, Tappy L. Campos V, et al. Nutrients. 2017 Feb 27;9(3):202. doi: 10.3390/nu9030202. Nutrients. 2017. PMID: 28264429 Free PMC article. Clinical Trial.
-
Teff KL, Elliott SS, Tschöp M, Kieffer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D'Alessio D, Havel PJ. Teff KL, et al. J Clin Endocrinol Metab. 2004 Jun;89(6):2963-72. doi: 10.1210/jc.2003-031855. J Clin Endocrinol Metab. 2004. PMID: 15181085 Clinical Trial.
-
Stanhope KL, Havel PJ. Stanhope KL, et al. Am J Clin Nutr. 2008 Dec;88(6):1733S-1737S. doi: 10.3945/ajcn.2008.25825D. Am J Clin Nutr. 2008. PMID: 19064538 Free PMC article. Review.
-
Dolan LC, Potter SM, Burdock GA. Dolan LC, et al. Crit Rev Food Sci Nutr. 2010 Nov;50(10):889-918. doi: 10.1080/10408398.2010.512990. Crit Rev Food Sci Nutr. 2010. PMID: 21108071 Review.
Cited by
-
Hieronimus B, Medici V, Lee V, Nunez MV, Sigala DM, Bremer AA, Cox CL, Keim NL, Schwarz JM, Pacini G, Tura A, Havel PJ, Stanhope KL. Hieronimus B, et al. Nutrients. 2024 Jan 2;16(1):151. doi: 10.3390/nu16010151. Nutrients. 2024. PMID: 38201980 Free PMC article.
-
Soltani Z, Rasheed K, Kapusta DR, Reisin E. Soltani Z, et al. Curr Hypertens Rep. 2013 Jun;15(3):175-81. doi: 10.1007/s11906-013-0344-5. Curr Hypertens Rep. 2013. PMID: 23588856 Free PMC article. Review.
-
Pollock NK, Bundy V, Kanto W, Davis CL, Bernard PJ, Zhu H, Gutin B, Dong Y. Pollock NK, et al. J Nutr. 2012 Feb;142(2):251-7. doi: 10.3945/jn.111.150219. Epub 2011 Dec 21. J Nutr. 2012. PMID: 22190023 Free PMC article.
-
Soft drinks consumption and nonalcoholic fatty liver disease.
Nseir W, Nassar F, Assy N. Nseir W, et al. World J Gastroenterol. 2010 Jun 7;16(21):2579-88. doi: 10.3748/wjg.v16.i21.2579. World J Gastroenterol. 2010. PMID: 20518077 Free PMC article.
References
-
- Putnam JJ, Allshouse JE 1999 Food consumption, prices and expenditures, 1970–1997. Economic Research Service. Washington, DC: U.S. Department of Agriculture
-
- Bray GA, Nielsen SJ, Popkin BM 2004 Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79:537–543 - PubMed
-
- Curry D 1989 Effects of mannose and fructose on the synthesis and secretion of insulin. Pancreas 4:2–9 - PubMed
-
- Teff KL, Elliott SS, Tschop M, Kieffer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D'Alessio D, Havel PJ 2004 Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 89:2963–2972 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DK-58108/DK/NIDDK NIH HHS/United States
- R21 AT002599/AT/NCCIH NIH HHS/United States
- DK-58003/DK/NIDDK NIH HHS/United States
- R03 DK058108/DK/NIDDK NIH HHS/United States
- AT-003645/AT/NCCIH NIH HHS/United States
- DK-19525/DK/NIDDK NIH HHS/United States
- R01 DK058003/DK/NIDDK NIH HHS/United States
- M01 RR000042/RR/NCRR NIH HHS/United States
- R01 HL075675/HL/NHLBI NIH HHS/United States
- R01 HL091333/HL/NHLBI NIH HHS/United States
- AT-002599/AT/NCCIH NIH HHS/United States
- HL-091333/HL/NHLBI NIH HHS/United States
- M01-RR00042/RR/NCRR NIH HHS/United States
- HL-075675/HL/NHLBI NIH HHS/United States
- R01 HL107256/HL/NHLBI NIH HHS/United States
- R21 AT003645/AT/NCCIH NIH HHS/United States
- P30 DK019525/DK/NIDDK NIH HHS/United States